Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Biohaven's Vyglxia (troriluzole). Show all posts
Showing posts with label Biohaven's Vyglxia (troriluzole). Show all posts
Tuesday, February 3, 2026

FDA Issues Complete Response Letter for Biohaven's Vyglxia (troriluzole) New Drug Application for Spinocerebellar Ataxia

›
Biohaven Ltd. (NYSE: BHVN) ("Biohaven"), a global clinical-stage biopharmaceutical company focused on the discovery, development a...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.